Quantcast
Channel: The Cross-Border Biotech Blog » Allergan
Browsing latest articles
Browse All 2 View Live

Image may be NSFW.
Clik here to view.

A Third REMS Advantage? Allergan Says REMS for Botox Requires Off-Label...

Allergan sued the FDA earlier this month, claiming that the FDA’s prohibition of off-label promotion violates Allergan’s First Amendment rights by preventing Allergan from communicating about BOTOX’s...

View Article



Image may be NSFW.
Clik here to view.

Monday Biotech Deal Review: February 14, 2011

Welcome to the Monday Biotech Deal Review for February 14, 2011.  Aside from the usual assortment of corporate and regulatory announcements over the week, the highlights include SemBioSys’ proposed $4M...

View Article
Browsing latest articles
Browse All 2 View Live




Latest Images